Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,538
Total Claims
$989K
Drug Cost
851
Beneficiaries
$1,162
Cost/Patient
Risk Score Breakdown 12/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-38%
Opioid rate vs peers
1.4% vs 2.2% avg
-18%
Cost per patient vs peers
$1,162 vs $1,411 avg
+51%
Brand preference vs peers
16.0% vs 10.6% avg
Opioid Prescribing
1.4%
Opioid Rate
160
Opioid Claims
$3,213
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,822 claims · $682K
Generic: 9,541 claims · $298K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 291 | $117K |
| Sitagliptin Phosphate | 142 | $73K |
| Semaglutide | 54 | $59K |
| Empagliflozin | 49 | $53K |
| Tetrabenazine | 52 | $47K |
| Insulin Glargine,hum.Rec.Anlog | 185 | $32K |
| Sitagliptin Phos/Metformin Hcl | 28 | $30K |
| Lactulose | 256 | $21K |
| Sacubitril/Valsartan | 38 | $18K |
| Budesonide/Formoterol Fumarate | 39 | $18K |
| Insulin Glargine,hum.Rec.Anlog | 184 | $18K |
| Insulin Aspart | 73 | $17K |
| Diclofenac Sodium | 33 | $16K |
| Dulaglutide | 18 | $15K |
| Linagliptin | 14 | $14K |
Prescribing Profile
Patient Profile
75
Avg Age
61%
Female
1.86
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data